• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

PSMA PET-CT: the winner takes it all.

作者信息

Lazzeri Massimo, Chiti Arturo

机构信息

Department of Biomedical Sciences, Humanitas University, Via Rita Levi Montalcini 4, 20090, Pieve Emanuele, Milan, Italy.

Department of Urology, IRCCS Humanitas Research Hospital, via Manzoni 56, 20089, Rozzano, Milan, Italy.

出版信息

Eur J Nucl Med Mol Imaging. 2021 Nov;48(12):3760-3761. doi: 10.1007/s00259-021-05534-6.

DOI:10.1007/s00259-021-05534-6
PMID:34432119
Abstract
摘要

相似文献

1
PSMA PET-CT: the winner takes it all.前列腺特异性膜抗原正电子发射断层扫描-计算机断层扫描（PSMA PET-CT）：胜者通吃。
Eur J Nucl Med Mol Imaging. 2021 Nov;48(12):3760-3761. doi: 10.1007/s00259-021-05534-6.
2
Ga-Labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Computed Tomography for Prostate Cancer: A Systematic Review and Meta-analysis.Ga 标记前列腺特异性膜抗原配体正电子发射断层扫描/计算机断层扫描在前列腺癌中的应用：系统评价和荟萃分析。
Eur Urol Focus. 2018 Sep;4(5):686-693. doi: 10.1016/j.euf.2016.11.002. Epub 2016 Nov 15.
3
The role of PSMA PET/CT imaging in restaging of prostate cancer patients with low prostate-specific antigen levels.前列腺特异性抗原水平较低的前列腺癌患者再分期中PSMA PET/CT成像的作用。
Nucl Med Commun. 2017 Feb;38(2):149-155. doi: 10.1097/MNM.0000000000000617.
4
Whole-Body Integrated [Ga]PSMA-11-PET/MR Imaging in Patients with Recurrent Prostate Cancer: Comparison with Whole-Body PET/CT as the Standard of Reference.全身整合 [Ga]PSMA-11-PET/MR 成像在复发性前列腺癌患者中的应用：与全身 PET/CT 作为参考标准的比较。
Mol Imaging Biol. 2020 Jun;22(3):788-796. doi: 10.1007/s11307-019-01424-4.
5
The impact of [Ga]PSMA I&T PET/CT on radiotherapy planning in patients with prostate cancer.[Ga]PSMA I&T PET/CT 对前列腺癌患者放疗计划的影响。
Strahlenther Onkol. 2018 Jul;194(7):646-654. doi: 10.1007/s00066-018-1291-5. Epub 2018 Mar 23.
6
Efficacy, Predictive Factors, and Prediction Nomograms for Ga-labeled Prostate-specific Membrane Antigen-ligand Positron-emission Tomography/Computed Tomography in Early Biochemical Recurrent Prostate Cancer After Radical Prostatectomy.根治性前列腺切除术后早期生化复发前列腺癌 Ga 标记前列腺特异性膜抗原配体正电子发射断层扫描/计算机断层扫描的疗效、预测因素和预测列线图。
Eur Urol. 2018 May;73(5):656-661. doi: 10.1016/j.eururo.2018.01.006. Epub 2018 Jan 19.
7
The role of 68Ga-PSMA PET/CT scan in biochemical recurrence after primary treatment for prostate cancer: a systematic review of the literature.68Ga-PSMA PET/CT扫描在前列腺癌初次治疗后生化复发中的作用：文献系统综述
Minerva Urol Nefrol. 2018 Oct;70(5):462-478. doi: 10.23736/S0393-2249.18.03081-3. Epub 2018 Apr 17.
8
Treatment Outcomes from Ga-PSMA PET/CT-Informed Salvage Radiation Treatment in Men with Rising PSA After Radical Prostatectomy: Prognostic Value of a Negative PSMA PET.根治性前列腺切除术后 PSA 升高男性患者接受 Ga-PSMA PET/CT 引导下挽救性放射治疗的疗效：PSMA PET 阴性的预后价值
J Nucl Med. 2017 Dec;58(12):1972-1976. doi: 10.2967/jnumed.117.196683. Epub 2017 Jul 26.
9
Diagnostic Accuracy of Ga-68-HBED-CC-PSMA-Ligand-PET/CT before Salvage Lymph Node Dissection for Recurrent Prostate Cancer.用于复发性前列腺癌挽救性淋巴结清扫术前的Ga-68-HBED-CC-PSMA配体-PET/CT的诊断准确性
Theranostics. 2017 Apr 10;7(6):1770-1780. doi: 10.7150/thno.18421. eCollection 2017.
10
Immunohistochemical PSMA expression patterns of primary prostate cancer tissue are associated with the detection rate of biochemical recurrence with Ga-PSMA-11-PET.原发前列腺癌组织中 PSMA 的免疫组化表达模式与 Ga-PSMA-11-PET 检测生化复发的检出率相关。
Theranostics. 2020 May 15;10(14):6082-6094. doi: 10.7150/thno.44584. eCollection 2020.

引用本文的文献

1
Things are because we see them (O. Wilde): new radiopharmaceuticals for nuclear medicine imaging.事物因我们观察而存在（奥斯卡·王尔德）：用于核医学成像的新型放射性药物
Eur J Nucl Med Mol Imaging. 2022 Aug;49(10):3320-3321. doi: 10.1007/s00259-022-05768-y.
2
Dual-tracer PET/CT-targeted, mpMRI-targeted, systematic biopsy, and combined biopsy for the diagnosis of prostate cancer: a pilot study.双示踪剂 PET/CT 靶向、mpMRI 靶向、系统活检和联合活检在前列腺癌诊断中的应用：一项初步研究。
Eur J Nucl Med Mol Imaging. 2022 Jul;49(8):2821-2832. doi: 10.1007/s00259-021-05636-1. Epub 2021 Dec 3.

本文引用的文献

1
Antibodies targeting Prostate-Specific Membrane Antigen positive prostate cancer: from diagnostic imaging to theranostics.靶向前列腺特异性膜抗原阳性前列腺癌的抗体：从诊断成像到治疗诊断学。
Curr Opin Oncol. 2021 Sep 1;33(5):500-506. doi: 10.1097/CCO.0000000000000767.
2
Cancer Statistics, 2021.癌症统计数据，2021.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
3
EAU-EANM-ESTRO-ESUR-SIOG Guidelines on Prostate Cancer-2020 Update. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent.
EAU-EANM-ESTRO-ESUR-SIOG 前列腺癌指南-2020 版更新。第 1 部分：筛查、诊断和以治愈为目的的局部治疗。
Eur Urol. 2021 Feb;79(2):243-262. doi: 10.1016/j.eururo.2020.09.042. Epub 2020 Nov 7.
4
PSMA-PET and micro-ultrasound potential in the diagnostic pathway of prostate cancer.前列腺特异性膜抗原正电子发射断层扫描（PSMA-PET）和微超声在前列腺癌诊断路径中的潜力。
Clin Transl Oncol. 2021 Jan;23(1):172-178. doi: 10.1007/s12094-020-02384-w. Epub 2020 May 23.
5
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study.高风险前列腺癌患者在接受根治性手术或放疗前的前列腺特异性膜抗原 PET-CT（proPSMA）：一项前瞻性、随机、多中心研究。
Lancet. 2020 Apr 11;395(10231):1208-1216. doi: 10.1016/S0140-6736(20)30314-7. Epub 2020 Mar 22.
6
Ga Prostate-specific Membrane Antigen PET/CT for Primary Diagnosis of Prostate Cancer: Complementary or Alternative to Multiparametric MR Imaging.镓前列腺特异性膜抗原PET/CT用于前列腺癌的初步诊断：多参数磁共振成像的补充还是替代
Radiology. 2018 May;287(2):725-726. doi: 10.1148/radiol.2017172607.